Vivaldi Capital Management LP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vivaldi Capital Management LP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,981
+33.3%
19,2610.0%0.01%
+33.3%
Q2 2023$27,736
-31.4%
19,2610.0%0.01%
-25.0%
Q1 2023$40,448
+79.5%
19,2610.0%0.01%
+100.0%
Q4 2022$22,535
-24.9%
19,2610.0%0.01%
-25.0%
Q3 2022$30,000
+36.4%
19,261
+12.8%
0.01%
+33.3%
Q2 2022$22,000
-4.3%
17,0780.0%0.01%0.0%
Q1 2022$23,000
+4.5%
17,078
+60.1%
0.01%
+20.0%
Q4 2021$22,000
-46.3%
10,6680.0%0.01%
-44.4%
Q3 2021$41,000
+13.9%
10,6680.0%0.01%
+28.6%
Q2 2021$36,000
-20.0%
10,6680.0%0.01%
-22.2%
Q1 2021$45,000
+28.6%
10,668
-30.9%
0.01%
+28.6%
Q4 2020$35,000
-16.7%
15,4390.0%0.01%
-22.2%
Q3 2020$42,000
+5.0%
15,4390.0%0.01%
+12.5%
Q2 2020$40,000
+90.5%
15,439
+44.7%
0.01%
+60.0%
Q1 2020$21,000
-32.3%
10,6680.0%0.01%
-28.6%
Q4 2019$31,000
-20.5%
10,6680.0%0.01%
-22.2%
Q3 2019$39,000
-11.4%
10,6680.0%0.01%
-18.2%
Q2 2019$44,00010,6680.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders